Related Experiment Videos

A pitfall in the meta-analysis of hazard ratios

U R Abel¹, L Edler

¹Deutsches Krebsforschungszentrum, Institut für Epidemiologie und Biometrie, Heidelberg, West Germany.

Controlled Clinical Trials

|June 1, 1988

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV.

European journal of cancer (Oxford, England : 1990)·2014

Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer.

Investigational new drugs·2010

MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome.

British journal of cancer·2010

Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis.

The European respiratory journal·2009

A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV.

British journal of cancer·2007

Risk assessment of substances that are both genotoxic and carcinogenic report of an International Conference organized by EFSA and WHO with support of ILSI Europe.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2006

See all related articles